Publication: The Innovative Medicines Initiative: A European Response to the Innovation Challenge

The Innovative Medicines Initiative (IMI) was launched in 2008 as a large-scale public–private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). With a total budget of €2 billion, the IMI aims to boost the development of new medicines across Europe by implementing new collaborative endeavors between large pharmaceutical Read more about Publication: The Innovative Medicines Initiative: A European Response to the Innovation Challenge[…]